Form 4/A for CME CME Group
Accepted 2024-04-03 00:00:00 ET · period of report 2024-03-15 · accession 0001156375-24-000067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-04-03 | 2024-03-15 | CME | McCourt Timothy Francis | Sr MD Gbl Head Equity, FX | A - Grant | $217.50 | +556 | 6,830 | +9% | +$120.9K |
| MA | 2024-04-03 | 2024-03-15 | CME | McCourt Timothy Francis | Sr MD Gbl Head Equity, FX | F - Tax | $217.50 | -383 | 6,447 | -6% | -$83.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock Class A | 2024-03-15 | A | A | 556 | $217.50 | 6,830 | D | — | — | (F2) Represents shares earned from a 2020 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2021-2023. (F3) The amount of shares beneficially owned also has been adjusted to reflect the sale of 35 shares that was reported on the Form 4 filed on March 22, 2024. |
| 2 | Common | Common Stock Class A | 2024-03-15 | F | D | 284 | $217.50 | 6,546 | D | — | — | (F4) Mr. McCourt surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. (F3) The amount of shares beneficially owned also has been adjusted to reflect the sale of 35 shares that was reported on the Form 4 filed on March 22, 2024. |
| 3 | Common | Common Stock Class A | 2024-03-15 | F | D | 99 | $217.50 | 6,447 | D | — | — | (F5) Mr. McCourt surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2024. (F3) The amount of shares beneficially owned also has been adjusted to reflect the sale of 35 shares that was reported on the Form 4 filed on March 22, 2024. |